. 2007 Jun 27;41(1):50–57. doi: 10.3164/jcbn.2007007

Table 2.

Comparison of MDA, TAC, CRP, NT-proBNP, TnT and CK-MB in patient groups and control group

	MDA (nmol/ml)	TAC (µmol/l)	CRP (mg/dl)	NT-proBNP (pg/ml)	TnT (ng/ml)	CK-MB (U/l)
Hypertension group (n = 17)	4.67 ± 0.40^a	1.19 ± 0.04^a	1.33 ± 0.18^a	847.98 ± 140.90^a	1.32 ± 0.37^a	126.06 ± 34.71^a
Cardiovascular group (n = 9)	4.08 ± 0.54^a	1.22 ± 0.07	1.71 ± 0.15^a	2216.16 ± 668.48^a ⁱ	1.47 ± 0.44^a	155.00 ± 45.23^a
Cardiovascular + hypertension group (n = 28)	4.90 ± 0.49^a	1.27 ± 0.04	1.73 ± 0.11^a ⁱ	1957.86 ± 255.19^a ^h	1.28 ± 0.29^a	115.43 ± 17.80^a
Hypertension + hyperlipidemia group (n = 13)	4.28 ± 0.64^a	1.29 ± 0.07	1.98 ± 0.19^a ⁱ	1681.87 ± 569.82^a	1.21 ± 0.33^a	109.23 ± 20.42^a
Hyperlipidemia / diabetes / renal group (n = 11)	5.72 ± 0.68^a	1.39 ± 0.08ⁱ	1.81 ± 0.17^a	1288.29 ± 292.61^a	0.95 ± 0.35^a	183.55 ± 48.39^a
Non-disease group (n = 22)	3.71 ± 0.47^b ^g	1.27 ± 0.04	1.15 ± 0.13^a ^c ^d ^e ^f	818.23 ± 210.91^a ^c ^d	0.88 ± 0.30^a	84.59 ± 14.23^a ^g
Total patients (n = 100)	4.53 ± 0.22^a	1.27 ± 0.02	1.57 ± 0.07^a	1432.17 ± 140.64^a	1.17 ± 0.14^a	120.70 ± 11.08^a
Controls (n = 40)	2.68 ± 0.14	1.33 ± 0.02	0.58 ± 0.03	93.23 ± 3.25	0.01 ± 0.00	12.55 ± 0.82

significant difference from control group (p<0.01),

significant difference from control group (p<0.05),

significant difference from cardiovascular group (p<0.05),

significant difference from cardiovascular + hypertension group (p<0.01),

significant difference from hypertension + hyperlipidemia group (p<0.01),

significant difference from hyperlipidemia + diabetes + renal group (p<0.01),

significant difference from hyperlipidemia + diabetes + renal group (p<0.05),

significant difference from hypertension group (p<0.01,

ⁱ

significant difference from hypertension group (p<0.05).